Authors:
DUNBAR C
KOHN D
KARLSSON S
BARTON N
BRADY R
COTTLERFOX M
CROOKS G
EMMONS R
ESPLIN J
LEITMAN S
LENARSKY C
NOLTA J
PARKMAN R
PENSIERO M
SCHIFMANN R
TOLSTOSHEV P
WEINBERG K
Citation: C. Dunbar et al., RETROVIRAL-MEDIATED TRANSFER OF THE CDNA FOR HUMAN GLUCOCEREBROSIDASEINTO HEMATOPOIETIC STEM-CELLS OF PATIENTS WITH GAUCHER DISEASE - A PHASE-I STUDY, Human gene therapy, 7(2), 1996, pp. 231-253
Authors:
MERROUCHE Y
NEGRIER S
BAIN C
COMBARET V
MERCATELLO A
CORONEL B
MOSKOVTCHENKO JF
TOLSTOSHEV P
MOEN R
PHILIP T
FAVROT MC
Citation: Y. Merrouche et al., CLINICAL-APPLICATION OF RETROVIRAL GENE-TRANSFER IN ONCOLOGY - RESULTS OF A FRENCH STUDY WITH TUMOR-INFILTRATING LYMPHOCYTES TRANSDUCED WITH THE GENE OF RESISTANCE TO NEOMYCIN, Journal of clinical oncology, 13(2), 1995, pp. 410-418
Authors:
BLAESE RM
CULVER KW
MILLER AD
CARTER CS
FLEISHER T
CLERICI M
SHEARER G
CHANG L
CHIANG YW
TOLSTOSHEV P
GREENBLATT JJ
ROSENBERG SA
KLEIN H
BERGER M
MULLEN CA
RAMSEY WJ
MUUL L
MORGAN RA
ANDERSON WF
Citation: Rm. Blaese et al., T-LYMPHOCYTE-DIRECTED GENE-THERAPY FOR ADA(-) SCID - INITIAL TRIAL RESULTS AFTER 4 YEARS, Science, 270(5235), 1995, pp. 475-480
Authors:
SMITH T
WHITE B
TOLSTOSHEV P
KALEKO M
MCCLELLAND A
Citation: T. Smith et al., LONG-TERM IN-VIVO EXPRESSION AND EFFECTIVE REPEAT DELIVERY OF A NOVELADENOVIRUS VECTOR CONTAINING A HUMAN FACTOR-IX MINIGENE, Blood, 86(10), 1995, pp. 945-945
Authors:
MITTEREDER N
YEI SP
BACHURSKI C
CUPPOLETTI J
WHITSETT JA
TOLSTOSHEV P
TRAPNELL BC
Citation: N. Mittereder et al., EVALUATION OF THE EFFICACY AND SAFETY OF IN-VITRO, ADENOVIRUS-MEDIATED TRANSFER OF THE HUMAN CYSTIC-FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR CDNA, Human gene therapy, 5(6), 1994, pp. 717-729
Authors:
PENSIERO MN
HIRSCH J
JACOBSON MG
ANDERSON WF
TOLSTOSHEV P
TRAPNELL BC
Citation: Mn. Pensiero et al., COMPLETE NUCLEOTIDE-SEQUENCE OF 4070A, AN AMPHOTROPIC MURINE RETROVIRUS, Journal of cellular biochemistry, 1994, pp. 228-228
Authors:
TRAPNELL BC
MITTEREDER N
YEI SP
CHANG YN
TOLSTOSHEV P
Citation: Bc. Trapnell et al., DEVELOPMENT OF RECOMBINANT ADENOVIRUS VECTORS FOR CLINICAL USE IN GENE-THERAPY FOR GENETIC AND ACQUIRED DISORDERS, Journal of cellular biochemistry, 1993, pp. 204-204
Citation: P. Tolstoshev, GENE-THERAPY, CONCEPTS, CURRENT TRIALS AND FUTURE-DIRECTIONS, Annual review of pharmacology and toxicology, 33, 1993, pp. 573-596